A team of biologists from the University and the University Hospital in Basel, Switzerland, developed a drug that could help with cancer, reports the publication, where they showed the results of the study in the journal Cell.
According to the article, they had to test 2,486 different compounds (all approved by the US Food and Drug Administration or FDA) to find the perfect combination to stop the spread of malignant cancer cells. After selecting components, experts will begin clinical trials in patients who are suffering from breast cancer.
It should be noted that metastasis begins when circulating tumor cells or CCS enter the bloodstream and infect the body after they have "sowed" the primary tumor. This process contributes to "distant" metastasis and accelerates the development of various types of cancer.
After understanding this concept, Swiss scientists have found a way to change epigenetic changes that cause the formation of CPC groups, and which, in turn, facilitate the "sowing of metastases."
By stopping this process, they counteract cancer, and the possibility that the candidate develops the disease can be cured satisfactorily.